Virdev Intermediates

BDR Group of companies has grown steadily and become a household name in the pharmaceutical industry over the last 15 years, recognized for manufacturing Pharmaceutical APIs and new age formulations. The group focuses on development in specialized therapeutic segments, including Oncology, Critical care, Gynecology, and Neurology. BDR has built a reputation for early identification, development, and introduction of new molecules, aiming to make high-cost medicines available to local masses at affordable prices. A state-of-the-art manufacturing unit for Oncology oral formulations is already commissioned and compliant with WHO GMP and EU-GMP standards.